VC
Value Add VC
โšกHomePulseโšกHelpful Apps๐Ÿ“Blog
โ† Value Add PulseBIG TECH~-20% stock drop

Cerebras Plunges ~20% in Its First Earnings as a Public Company on a Margin Scare

Cerebras shares fell roughly 20% -- back near their IPO price -- after the AI-chip maker's first earnings report as a public company spooked investors with a soft gross-margin outlook, even as it beat on revenue. CEO Andrew Feldman said the market 'misunderstood' the guidance, which reflects a temporary plan to lease back systems while it builds its own data centers.

~-20%
Stock Move
$193M (+94% YoY)
Q1 Revenue
$14M (from $23.9M)
Net Loss
47%
Q1 Gross Margin
38-41%
FY Margin Guide
TC
Trace Cohen
Early-stage VC & angel ยท Founder, New York Venture Partners
June 24, 2026
2 min read
ShareXLinkedInEmail
THE RUNDOWN
1

The cycle's hottest chip IPO just got a hard lesson: forward guidance trumps a revenue beat

2

A drop to near the IPO price tests conviction in the whole AI-hardware listing wave

3

Margin compression from leasing back systems shows how capital-intensive scaling AI compute really is

4

How Cerebras trades sets the tone for the IPO pipeline behind it, from Ambiq to the AI labs

TC
The VC Read ยท Trace's TakeTrace Cohen

This is the lesson every late-stage founder eyeing an IPO should tattoo on their wrist: public markets reprice you every second on the future, not the quarter, and a 94% revenue beat means nothing next to a soft margin guide. Feldman may be right that the leaseback is transitory, but 'investors misunderstood' is the most expensive sentence a public CEO can say. The real signal here isn't Cerebras -- it's the message to Ambiq, the AI labs, and everyone behind them in the IPO line: the window is open, but it has no patience for a fuzzy unit-economics story. Watch whether it reclaims its highs; that's the true read on AI-hardware appetite.

๐Ÿ“ˆ 2026 IPO Tracker โ†’โšก AI Chip Wars โ†’

Cerebras Systems, the wafer-scale AI-chip company that completed one of the year's most anticipated IPOs, dropped roughly 20% on Wednesday after its first earnings report as a public company, according to TechCrunch. The selloff pushed the stock back toward its IPO price even though the company beat expectations on the top line.

The quarter itself looked strong: revenue of $193 million, up 94% year over year, with a net loss narrowing to $14 million from $23.9 million a year earlier. What spooked the market was guidance -- full-year gross margins of 38-41%, a meaningful step down from the 47% Cerebras posted in the quarter. In a market priced for perfection, a margin guide-down is enough to erase a revenue beat.

CEO Andrew Feldman pushed back, saying investors had 'misunderstood' the outlook. He explained that Cerebras plans to temporarily lease back some of its own systems from a major customer while it builds out its own data-center capacity -- a near-term drag on profitability that, in his telling, reflects investment rather than deterioration. It is a nuanced story that did not survive contact with a jittery tape.

โ€œThe quarter itself looked strong: revenue of $193 million, up 94% year over year, with a net loss narrowing to $14 million from $23.9 million a year earlier.โ€

The episode is a textbook lesson in the gravity of public markets. Private AI valuations have been set by scarcity and narrative; public ones are set every second by investors who punish any whiff of softening unit economics. Cerebras shares the spotlight with a cohort of richly valued AI-hardware names, and its customer concentration -- historically anchored by a small number of large buyers -- has long been a question mark that public scrutiny now magnifies.

The read-through matters for the entire pipeline. With Ambiq Micro racing to price and the AI labs themselves circling confidential S-1s, how Cerebras trades through this is a live demand signal. A name that round-trips to its IPO price on its first stumble tells late-stage founders and their bankers that the public market will pay up for AI -- but will not tolerate a fuzzy margin story. The bull case is that a 94% growth rate and a credible capacity buildout get rewarded once the leaseback noise clears; the bear case is that this is the first crack in AI-hardware multiples.

What to watch: whether the margin guide is truly transitory or the start of a trend, customer concentration disclosures, and whether the stock can reclaim its post-IPO highs -- the cleanest barometer of public appetite for the AI-silicon trade.

ShareXLinkedInEmail
More onCerebras โ†’

Originally reported by TechCrunch. Analysis and editorial commentary by Value Add Pulse.

โ† Back to Pulse

THE WIRE in your inboxโ€” Tech, startup & VC news with Trace's take. Free, no spam.

Read Next

BIG TECH-24% SOX drawdown

Chip Stocks Enter Bear Market as AI Rally Cracks

The Philadelphia Semiconductor Index has fallen 24% from its June record into a confirmed bear market after Moonshot AI's cut-rate Kimi K3 model undercut the thesis that frontier-adjacent AI requires frontier-level compute spend.

BIG TECH$1.8B all-cash

Samsung Biologics Buys PolyPeptide in $1.8B Cash Deal

Samsung Biologics agreed to acquire Switzerland's PolyPeptide Group in an all-cash deal valuing the contract drugmaker's equity at roughly $1.8 billion, extending a wave of large biotech and pharma manufacturing consolidation through 2026.

BIG TECH$53.4B buyout bid

PayPal's Board Meets Today to Weigh Stripe's $53B Bid

PayPal's board is convening as soon as today to weigh a $53 billion buyout offer from Stripe and Advent International at $60.50 a share, a bid that would make Stripe co-owner of the payments company it once tried to disrupt.

@Trace_Cohenยทt@nyvp.com